Phase 4 N=7 Varenicline for Co-occurring Cannabis and Tobacco Use
Cannabis Dependence · Tobacco Dependence
Primary: Enrollment Rate — 7 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=129 Cognitive Behavioral Therapy (REBT/CBT) Evaluation for Dysthymia in the Practice of Clinical Social Work at Primary Care
Depression · Dysthymia · Ambulatory Health Services
Primary: Change From Baseline in Severity of Depression, Measured According to the Beck Depression Inventory, at 4 and 12 Months. — 16.18; 19.90; 16.29; 20.90 score on a scale
Phase 1 N=68 Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.
Osteopenia · Osteoporosis · Bone Disease
Primary: Number of Participants With Dose-Limiting or Intolerable Treatment Related Adverse Events (AEs) — 0; 0; 0; 0 Participants
Phase 2 N=123 Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
Sickle Cell Disease
Primary: Percentage of Participants With Overall Survival (OS) at 2 Years After Biologic Assignment — 89; 94 percentage of participants
Phase 1 N=6 A Study to Understand How the Study Medicine (PF-07081532) is Processed and Eliminated in Healthy Men
Healthy Participants
Primary: Total Recovery of Radioactivity in Urine, Feces and Both Routes Combined, as Percentage of Orally Administered Radioactive Dose of [14C]PF-07081532 — 4.7; 78.6; 83.4…
N/A N=4 BioWare for AUD and PTSD
PTSD · Alcohol Use Disorder
Primary: Percentage of Participants Who Turn on and Off Equipment in 5 Minutes or Less — 2 Participants
Phase 3 N=120 A Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol A
Macular Telangiectasia Type 2 (MacTel)
Primary: The Rate of Change in the Area of EZ Area of Loss From Baseline Through Month 24 — 0.075; 0.166 mm^2 — p=<0.0001
Phase 2 N=4 MK-3795 (PT2385) for the Treatment of Von Hippel-Lindau Disease-Associated Clear Cell Renal Cell Carcinoma (MK-3795-003)
VHL Gene Mutation · VHL · VHL Syndrome
Primary: Overall Response Rate (ORR) in VHL Disease-Associated ccRCC Tumors — 0.0 Percentage of Participants
Phase 3 N=6,102 A Study of mRNA-1010 Seasonal Influenza Vaccine in Adults
Seasonal Influenza
Primary: Geometric Mean Titer (GMT) of Anti-Hemagglutinin (HA) Antibodies at Day 29, as Measured by Hemagglutination Inhibition (HAI) Assay for Vaccine-matched Influenza A and B…
Phase 3 N=5 A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)
Progressive Familial Intrahepatic Cholestasis (PFIC)
Primary: Change in the Average Morning Itch Reported Outcome (ItchRO) (Observer Instrument [Obs]) Severity Score Between Baseline and the Average of Week 15 Through Week 26…
N/A N=590 Fatigue Management Programs for People With MS
Multiple Sclerosis
Primary: Change From Baseline in Fatigue Levels — 50.98; 56.88; 57.87 score on a scale
N/A N=28 Cognitive-Behavioral Therapy for Weight-related Bullying (Online Treatment)
Bullying · Weight, Body · Trauma, Psychological
Primary: Stress — 20.55 units on a scale — p=.047
N/A N=252 This Study is to Describe and Evaluate Patients in Finland Treated With Tofacitinib for the Treatment of Ulcerative Colitis Using Real World Data.
Ulcerative Colitis
Primary: Age at the Time of Diagnosis — 31.08 Years
Phase 1 N=100 A Gender-Enhanced Pre-Exposure Prophylaxis (PrEP) Information-Motivational Workshop for Young South African Women
HIV Infections
Primary: Percent of Participants Who Have an Individual Counseling Session About PrEP. — 28; 28 Participants — p=1.0
N/A N=60 Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose Metabolism
Fatty Liver Disease · Type 2 Diabetes · Impaired Glucose Regulation
Primary: Change of Liver Fat Content in % — -20.5; -15.5; -7.6; -7.3 absolute fat content change in %